Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098 by Griet, Milagros et al.
RESEARCH ARTICLE
Two-step production of anti-inflammatory
soluble factor by Lactobacillus reuteri CRL 1098
Milagros Griet, Graciela Font de Valdez, Carla L. Gerez*, Ana V. Rodrı´guez
Centro de Referencia para Lactobacilos (CERELA), Consejo Nacional de Investigaciones Cientı´ficas y
Te´cnicas (CONICET), San Miguel de Tucuma´n, Tucuma´n, Argentina
* clugerez@cerela.org.ar
Abstract
We have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.)
reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In
this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i)
bacterial biomass production, ii) LrS production, where the bacterial biomass was able to
live but did not proliferate. Therefore, the simultaneous evaluation of the effect of different
factors on the growth and LrS production was performed. Biomass production was found to
be dependent mainly on culture medium, while LrS production with anti-inflammatory activity
depended on culture conditions of the biomass such as pH, agitation and growth phase. The
L. reuteri CRL 1098 biomass and LrS production in the optimized culture media designed for
this work reduced the complete process cost by approximately 95%, respectively to labora-
tory scale cost.
Introduction
In the past decades, several worksdemonstrated the capacity of probiotic lactic acid bacteria
(LAB) to modulate immune response. In this way, some strains may have prophylactic and
therapeutic effect in different complex disorders, including inflammatory diseases [1–4]. In
addition, increased research reports revealed that certain surface-associated and extracellular
components produced by probiotic bacteria could be responsible for some of their beneficial
effects: they include exopolysaccharides, bacteriocins, surface-associated and extracellular pro-
teins and peptides and lipoteichoic acid [5–9].
The current demand for new products enriched with probiotics or its functional extracellu-
lar componentsrequires new economic media for their production at an industrial scale [10].
In probiotic product development processes, microbial biomass and bioactive metabolites are-
considered raw material. Thus, the cost of the culture media for the industrial production of
both is a determinant factor [11]. To produce significant biomass, Lactobacilli have complex
nutrient requirementssuch as amino acids, yeast extract, carbohydrates, vitamins and minerals
[12]. However, the use of these nutrient supplements in large quantities is very expensive [13].
Therefore, a development of new culture media taking into account nutrient requirements
and growth parameters could lead to a more economical probiotic production [14]. Statistical
PLOS ONE | https://doi.org/10.1371/journal.pone.0200426 July 6, 2018 1 / 17
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Griet M, de Valdez GF, Gerez CL,
Rodrı´guez AV (2018) Two-step production of anti-
inflammatory soluble factor by Lactobacillus reuteri
CRL 1098. PLoS ONE 13(7): e0200426. https://doi.
org/10.1371/journal.pone.0200426
Editor: Vasu D. Appanna, Laurentian University,
CANADA
Received: March 12, 2018
Accepted: June 26, 2018
Published: July 6, 2018
Copyright: © 2018 Griet et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: The authors acknowledge the financial
support of Consejo Nacional de Investigaciones
Cientı´ficas y Te´cnicas (CONICET, PIP 0512 and PIP
0611) from Argentina. The funders had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
methodology is efficiently used to optimize several bioprocesses such as the development of a
simplified, and hence more economical, culture medium, for biomass production [14–15]. In
this situation, the fractional factorial designs have been successfully applied for studying the
effects and interactions of distinct nutrients on Lactobacillus growth [15–17].
We have demonstrated previously, that L. reuteri CRL1098 can produce a supernatant (LrS)
able to reduce the TNF-α production by human peripheral blood mononuclear cells (PBMC)
[18]. Bearing in mind that TNF-α levels reduction is an effective treatment for inflammatory
diseases, we further investigated whether LrS was able to modulate the inflammatory response
used different models. For this, we used in vitro and in vivo models. Results showed that LrS
exerted anti-inflammatory actions in LPS-challenged murine macrophages model and in acute
lung injury induced by LPS in mice [19]. The compound present in LrS, responsible for the
anti-inflammatory actions, is a peptide moiety component. Using RP-HPLC, this peptide was
isolated keeping of the capacity to reduce the TNF-α production by PBMC. The peptide was
identified by mass spectrometry as 5785 Da [18], and its sequence analysis is currently in
progress.
At laboratory scale, the production of LrS involves two steps: production of L. reuteri
CRL1098 biomass until the early exponential growth phase in MRS broth [20], and then the
transfer of the obtained biomass to RPMI 1640 medium (GIBCO, Grand Island, NY, USA)
with incubation of 4 h, where the bacteria are able tolive but do not proliferate and produce
LrS (Fig 1). Some preliminary assays revealed that the compound is not associated with the
growth of L. reuteri and the extension of the incubation time in the second step does not
increase the anti-inflammatory activity of LrS (unpublished data).
The cost analysis of LrS production process reveals that MRS and RPMI 1640 media are
very expensive and they significantly increase the cost of production (LrS: 138.3 USD/L).
Therefore, the aims of this study were to formulate low-cost media for (i) L. reuteri CRL1098
biomass production (first step) using a fractional factorial design and (ii) LrS production (sec-
ond step). Fermentation parameters such as pH, culture agitation and bacterial growth phase
were also determined.
Materials and methods
Bacterial growth
L. reuteri CRL1098, an anti-inflammatory soluble factor producing strain, was provided by the
Culture Collection of Centro de Referencia para Lactobacilos, CERELA. Tucuma´n, Argentina.
Fig 1. Process for obtaining of anti-inflammatory-soluble factor (LrS) from L. reuteriCRL 1098 at laboratory scale.
https://doi.org/10.1371/journal.pone.0200426.g001
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Stock cultures were maintained at −20 ˚C in 10% reconstituted skim milk supplemented with
0.5% yeast extract, 1.0% glucose, and 10.0% glycerol (w/v). Prior to experimental use, cultures
were propagated (1%, v/v) in MRS medium containing per liter: 10 g meat peptone, 10 g meat
extract, 5 g yeast extract, 3 g sodium acetate, 2 g K2HPO4, 2 g ammonium citrate, 20 g glucose,
1 mL Tween 80, 0.2 g MgSO4.7H2O and 0.038 g MnSO4.H2O, final pH 6.5 [20], and incubated
at 37 ˚C for 18h without agitation.
First step: Design of a low-cost culture medium for L. reuteri CRL1098
biomass production
The 210−6 fractional factorial design was used to select significant culture medium components
affecting the L. reuteri CRL1098 biomass production. Design Expert version 7.0 statistical soft-
ware (Stat-Ease, Minneapolis, MN) was used for the experimental design and regression analy-
sis of the experimental data. The MRS culture medium was used as the base culture medium
for the growth of L. reuteri. The factors and levels taken into consideration were: meat peptone
(0.0, 0.5 and 1.0%), meat extract (0.0, 0.5 and 1.0%), yeast extract (0.0, 0.25 and 0.5%), sodium
acetate (0.0, 0.15 and 0.3%), K2HPO4 (0.0, 0.1 and 0.2%), ammonium citrate (0.0, 0.1 and
0.2%), glucose (0.5, 1.25 and 2.0%), Tween 80 (0.0, 0.05 and 0.1%), MgSO4.7H2O (0.0, 0.01
and 0.02%), MnSO4.H2O (0.0, 0.0019 and 0.0038%). A 2
10−6 fractional factorial design was uti-
lized to screen 38 different culture media defined in 2 blocks with three central points in each
block (Table 1). The batch fermentations were carried out in 100 mLPyrex bottles containing
80 mL of fermentation medium. The different culture media were inoculated (2% v/v) with
L. reuteri CRL1098 and incubated at 37˚C for 3h (exponential growth phase) without agitation.
The responses evaluated were LAB growth and pH changes (pHmeter PT-10 model, Sartorius
AG, Goettingen, Germany). Cell viability was determined by plating appropriate dilutions of
the cultures in MRS agar (MRS Britania, Buenos Aires, Argentina, plus 15 g/L agar). Plates
were incubated at 37˚C for 48h and the colony-forming units (CFU/mL) were determined.
Later, we evaluated the growth of L. reuteri CRL1098 in an optimized culture medium. In
addition, the effect of agitation and the ability of this biomass to produce LrS in RPMI 1640
medium were also determined. The batch fermentation experiments were carried out in for-
mulated culture medium (named PETG medium: 0.5% meat peptone, 0.5% meat extract, 0.1%
Tween 80 and 0.5% glucose). L. reuteri CRL1098 was inoculated (2% v/v) in 100 mL (Pyrex
bottles 100 mL) and incubated at 37˚C with and without agitation (rotary shaker at 150 rpm,
Marconi, Piracicaba, Brazil)for 3h. Batch culture experiments were performed under uncon-
trolled pH. Both cultures were centrifuged (8,000 g for 10 min), washed with phosphate-buff-
ered saline (PBS) and resuspended (7.5 LogCFU/mL) in RPMI 1640 medium (GIBCO, Grand
Island, NY, USA). These bacterial suspensions were incubated for 4h at 37˚C in agitating
conditions (rotary shaker at 150 rpm). After, the suspensions were centrifuged and LrS was
obtained by aseptic filtration using 0.22 mm pore size low protein binding cellulose acetate fil-
ters (Millipore, Bedford, MA, USA). LrS was frozen at -20˚C for further experiments. The
anti-inflammatory activity of LrS was determined as described below.
On an industrial scale, the lactic cultures are produced in bioreactors and harvested in sta-
tionary phase when the maximum biomass production is reached. Therefore, the L. reuteri
CRL1098 biomass production in bioreactors and the obtaining of LrS in RPMI 1640 medium
were evaluated. To accomplish this, batch fermentations were performed in a 2 L bioreactor
(INFORS HT, Switzerland). The PETG medium (1.5 L, pH 6.5) was added to the bioreactor
and inoculated with L. reuteri CRL 1098 cultures (2%, v/v). During 24h fermentation, the tem-
perature was maintained at 37 ˚C, the agitation speed at 150 rpm. Batch cultures experiments
were performed under controlled and uncontrolled pH. When the controlled pH experiment
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Table 1. Fractional factorial design and results of L. reuteri CRL1098 biomass production, ΔpH and cost of different growth medium.
Culturemedium Factors (%) Growth (Log CFU/mL) ΔpH] Cost (USD/L)
MP ME YE SA K AC G T Mg Mn
BLOCK 1
1 1 1 0 0 0 0.2 2 0.1 0 0 7.76 0.43 8.32
2 1 1 0 0.3 0.2 0 0.5 0.1 0 0 7.96 0.65 7.76
3 0 0 0 0.3 0 0 2 0 0 0 7.02 0.39 0.96
4 0 0 0.5 0 0 0 0.5 0.1 0 0 7.13 1.62 0.81
5 0 0 0.5 0 0.2 0 2 0 0.02 0.0038 7.27 0.75 1.59
6 1 1 0.5 0.3 0 0.2 0.5 0 0 0 7.70 0.37 8.43
7 1 1 0.5 0 0 0 0.5 0.1 0.02 0.0038 7.98 1.23 7.98
8 0 0 0.5 0.3 0 0.2 0.5 0 0.02 0.0038 7.06 0.24 1.27
9 1 1 0 0 0.2 0.2 0.5 0 0.02 0.0038 7.66 0.46 7.90
10 0.5 0.5 0.25 0.15 0.1 0.1 1.25 0.05 0.01 0.0019 7.69 0.54 4.74
11 0.5 0.5 0.25 0.15 0.1 0.1 1.25 0.05 0.01 0.0019 7.70 0.60 4.74
12 1 1 0.5 0 0.2 0 2 0 0 0 7.54 0.55 8.75
13 0 0 0.5 0.3 0.2 0.2 2 0.1 0 0 7.24 0.33 2.10
14 0.5 0.5 0.25 0.15 0.1 0.1 1.25 0.05 0.01 0.0019 7.74 0.68 4.74
15 0 0 0 0 0.2 0.2 0.5 0 0 0 7.02 0.26 0.73
16 0 0 0 0 0 0.2 2 0.1 0.02 0.0038 7.34 0.14 1.16
17 0 0 0 0.3 0.2 0 0.5 0.1 0.02 0.0038 7.13 0.32 0.59
18 1 1 0 0.3 0 0 2 0 0.02 0.0038 7.67 0.69 8.14
19 1 1 0.5 0.3 0.2 0.2 2 0.1 0.02 0.0038 7.94 0.47 9.27
BLOCK 2
20 0.5 0.5 0.25 0.15 0.1 0.1 1.25 0.05 0.01 0.0019 7.60 0.49 4.23
21 0.5 0.5 0.25 0.15 0.1 0.1 1.25 0.05 0.01 0.0019 7.79 0.50 4.23
22 1 0 0.5 0 0 0.2 2 0 0.02 0 6.16 0.38 4.49
23 1 0 0.5 0 0.2 0.2 0.5 0.1 0 0.0038 7.46 0.35 4.72
24 0 1 0.5 0.3 0.2 0 0.5 0 0 0.0038 7.66 0.44 4.53
25 1 0 0 0 0.2 0 2 0.1 0.02 0 7.56 0.91 3.81
26 1 0 0.5 0.3 0.2 0 0.5 0 0.02 0 7.69 0.21 4.53
27 1 0 0 0.3 0 0.2 0.5 0.1 0.02 0 7.66 0.21 4.10
28 0 1 0 0.3 0 0.2 0.5 0.1 0 0.0038 7.67 0.20 4.10
29 0 1 0.5 0 0 0.2 2 0 0 0.0038 7.58 0.31 4.49
30 0.5 0.5 0.25 0.15 0.1 0.1 1.25 0.05 0.01 0.0019 7.82 0.43 4.23
31 0 1 0 0 0 0 0.5 0 0.02 0 7.10 1.17 3.59
32 1 0 0.5 0.3 0 0 2 0.1 0 0.0038 7.83 0.61 4.35
33 1 0 0 0.3 0.2 0.2 2 0 0 0.0038 7.64 0.30 4.27
34 0 1 0.5 0.3 0 0 2 0.1 0.02 0 7.72 0.51 4.35
35 0 1 0 0.3 0.2 0.2 2 0 0.02 0 7.74 0.30 4.27
36 1 0 0 0 0 0 0.5 0 0 0.0038 7.27 1.36 3.59
37 0 1 0.5 0 0.2 0.2 0.5 0.1 0.02 0 7.84 0.40 4.72
38 0 1 0 0 0.2 0 2 0.1 0 0.0038 7.68 0.60 3.81
Factors: MP: meat peptone; ME: meat extract; YE: yeast extract; SA: sodium acetate; K: K2HPO4; AC: ammonium citrate; G: glucose; T: Tween 80; Mg: MgSO4.7H2O;
Mn: MnSO4.H2O.
central points,
]pH (pHinitial−pHfinal)
https://doi.org/10.1371/journal.pone.0200426.t001
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was conducted, pH was maintained at 5.5 by adding 2 M NaOH (pH value used to produce
biomass of Lactobacillus in our laboratory). Samples were withdrawn periodically to determine
cell growth (Log CFU/mL), acidification (pH) and glucose consumption. pH measurements
were determined with a digital pH meter (Altronix TPX 1, New York, USA).
In order to evaluate the effect of growth stages on the ability of the microorganism to pro-
duce LrS, the fermentation time in bioreactors was extended until to 24h. Cells obtained from
free and controlled pH cultures in different growth stages were centrifuged (8,000 g for 10
min), washed with phosphate-buffered saline (PBS), resuspended (7.5 Log CFU/mL) in RPMI
1640 medium and incubated for 4h at 37˚C in agitating conditions (rotary shaker at 150 rpm).
The bacterial suspension was centrifuged and LrS was aseptically filtered. The anti-inflamma-
tory activity of LrS was determined as described below.
Second step: Formulation of a low-cost medium for anti-inflammatory LrS
production
In the second step, L. reuteri CRL1098 biomass is resuspended in RPMI 1640 medium and
incubated for 4h (Fig 1). Under these experimental conditions, the microorganism was capable
of living but did not proliferate. In order to reduce the cost of RPMI medium, different media
and buffer solutions were tested.
The batch fermentation experiments were carried out in PETG medium with agitation
(150rpm), under uncontrolled pH condition during 6 h at 37˚C (optimized conditions to bio-
mass production in previous point). Culture were centrifuged (8,000 g for 10 min), washed
with phosphate-buffered saline (PBS) and, resuspended in the following media and solutions:
RPMI 1640 medium (control), DMEM medium (GIBCO, Grand Island, NY, USA), Bacto™Ca-
sitone medium (BD Biosciences. Becton, Dickinson and Company. CA, USA), phosphate
buffer saline (PBS), tris-(hydroxymethyl)-aminomethane (Tris buffer) and sodium citrate
buffer with and without glucose. All these media and solutions were later assayed. The bacte-
rial suspensions were incubated for 4h at 37˚C in agitating conditions (rotary shaker at 150
rpm); then they were centrifuged and aseptically filtered to obtain LrS. The anti-inflammatory
activity of LrS was determined as described below.
Anti-inflammatory activity of LrS
To study the anti-inflammatory activity of LrS, mouse macrophage cell line RAW 264.7 was
cultured in DMEM supplemented with 10% fetal bovine serum (FBS) (NATOCOR, Co´rdoba,
Argentina), 100 IU/mL penicillin and 100 mg/mL streptomycin and cultured at 37˚C in a 5%
CO2 incubator. Prior to the addition of LrS, cells were seeded in 24-well culture plates, lowed
to adhere for 8h at 37 ˚C in 5% CO2 atmosphere. Once LrS was added, the cells were incubated
for 4h. Finally, LPS (100 ng/mL final concentration) from Escherichia (E.) coli serotype O26:
B6 (Sigma, St. Louis, MO, USA) was added to cultures and incubated for 20 h. Different anti-
inflammatory parameters were determined. Nitric oxide (NO) concentrations in supernatants
of RAW 264.7 cells were determined by using Griess reagent (Promega Corporation, Madison,
WI, USA). 50 mL aliquots of medium were mixed with an equal volume of sulfanilamide solu-
tion (1% sulfanilamide in 5% phosphoric acid) at different times and left to stand for 10 min at
room temperature in the dark. Then, 50 mL of NED solution [0.1% N-(1-Naphthyl) ethylene-
diamine] were added and left to stand for 10 min at room temperature in the dark. The absor-
bance was measured at 540nm with a microplate reader (VERSAmax, Molecular devices,
Sunnyvale, CA, USA). Standard curve for sodium nitrite was used to acquire the level of NO
produced by treated RAW 264.7 cells.
Production of anti-inflammatory soluble factor by Lactobacillus reuteri
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TNF-α concentration was measured in cell free supernatants of RAW 264.7 cells using
enzyme-linked immunosorbent assay kits (ELISA Ready-Set- Go!eBioscience, San Diego, CA,
USA).
Statistical data analysis
All assays were performed at least in triplicate and the results were expressed as mean values
with standard deviations. Statistical analyses were performed using MINITAB 14 software
(State College, PA, USA). Comparisons were accomplished by ANOVA general linear model
followed by Fisher test. Statistically significant differences were defined at a p value <0.05.
Results
First step: Design of a low-cost culture medium for L. reuteri CRL1098
biomass production and evaluation of their functional property
The first step on the search for optimal conditions for biomass production was to identify the
variables with significant influence. The statistical design resulted into 38 culture media
defined in 2 blocks with three central points in each block (Table 1). Table 1 summarizes L.
reuteri CRL1098 growth (Log CFU/mL), ΔpH (pHinitial−pHfinal) and the cost of each medium
assayed. In most culture medium, the bacterial growth reached approximately 7.4–7.9Log
CFU/mL and significant changes in pH were detected (ΔpH 0.47 to 0.75). Remarkably, the
higher acidification was detected (ΔpH 1.62) in medium number 4; however, a low growth
(7.13 Log CFU/mL) was observed. The cost of each one of the media evaluated was different,
varying from 0.59 to 9.27 USD/L.
Three components of the culture medium; meat peptone, meat extract and Tween 80,
showed a positive effect on bacterial growth (Table 2). In addition, using this statistical design,
interaction effects among factors on the biomass production evidenced positive and negative
interactions (S1 Fig). The most important positive interaction occurred among meat peptone
and meat extract: an increase of meat peptone and meat extract concentration (from 0 to 1%)
improved L. reuteri growth. However, the intermediate value (0.5%) showed a similar growth
to the maximum concentration (1%). On the other hand, a positive effect of Tween 80 was
observed with the highest concentration (0.1%).
According to significant effect and interactions, the composition of the culture medium,
named PETGculture medium, was: an intermediate concentration (0.5%) of meat peptone and
Table 2. Predicted effects of the factors on the growth of L. reuteri CRL1098.
Factors Effect Coefficient p-Value
Meat peptone 0.13655 0.02963 0.004
Meat extract 0.19645 0.13687 0.001
Yeast extract 0.00125 -0.03802 0.965
Sodium acetate 0.02673 0.05201 0.366
K2HPO4 -0.02422 0.02653 0.409
Ammonium citrate -0.03422 -0.05575 0.259
Glucose 0.00437 0.03646 0.877
Tween 80 0.11259 0.09494 0.009
MgSO4.7H2O 0.04415 -0.01657 0.162
MnSO4.H2O 0.00651 0.04190 0.818
Significantly different effect (p<0.05).
https://doi.org/10.1371/journal.pone.0200426.t002
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meat extract, and a high concentration (0.1%) of Tween 80. Glucose was added at a minimal
concentration (0.5%) as a carbon source. To validate this medium, L. reuteri CRL1098 was cul-
tured both in MRS and PETG culture media for 3 h without agitation. L. reuteri CRL1098
growth in PETG culture medium, was similar to that observed in MRS medium (7.9 ± 0.02
Log CFU/mL), Thus, PETG culture medium could replace MRS medium and its cost was only
3.81 USD/L compared with 9.27 USD/L of MRS medium (Fig 1).
The culture conditions could affect the biomass yield as well as the functional properties of
Lactobacillus. Consequently, the current study evaluated different factors, such as culture
medium, agitation, pH and growth phases on biomass production and anti-inflammatory
activity of LrS obtained in RPMI 1640 medium. First, the effect of agitation on biomass pro-
duction was evaluated. Batch experiments were carried out in PETG culture medium with or
without agitation for 3h under uncontrolled pH at 37˚C. L. reuteri CRL1098 growth was
similar in both conditions (7.6 ± 0.2 Log CFU/mL). Subsequently, the production on LrS by
bacteria grown in both conditions was evaluated in RPMI 1640 medium, and their anti-
inflammatory effect was checked on LPS challenged RAW cells. Stimulation of cells with LPS
significantly increased NO production by RAW 264.7 cells (Fig 2). The levels of NO were sig-
nificantly lower (35%) in LPS-challenged cells treated with LrS produced by L. reuteri grown
under stirring conditions. However, this effect was not induced by the LrS produced by the
microorganism grown under static conditions: the levels of NO were the same than the ones
observed in LPS-challenged cells (Fig 2).
Considering that pH plays a key role in growth, its effect was evaluated in a laboratory bio-
reactor (1.5 l) with continuous agitation (150 rpm) under controlled and uncontrolled pH for
24 h (Fig 3). The cultures under uncontrolled pH conditions reached stationary growth phase
at 7 h incubation (8.0 ± 0.2 Log CFU/mL) (Fig 3). These values were achieved earlier (3h) at
controlled pH conditions. However, although pH was controlled, a significantly viability
Fig 2. Effect of LrS on NO production by RAW 264.7 macrophages. LrS production by bacteria grown in under
static and stirred conditions was evaluated in RPMI 1640 medium, and their anti-inflammatory effect was checked on
LPS challenged RAW cells. NO was measured in culture supernatants by Griess assay. Data are representative result of
three independent experiments. Values not sharing the same letter were significantly different (p-value<0.05).
https://doi.org/10.1371/journal.pone.0200426.g002
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decrease was observed after 6h of fermentation (Fig 3), probably because glucose was rapidly
and almost completely consumed: from 5.0 to 0.9 g/L at 6h, and only 0.27 g/L of glucose was
detected at 24h.
On an industrial scale, the lactic cultures are harvested in stationary phase when the maxi-
mum biomass production is reached. However, previous studies in our laboratory demon-
strated that L. reuteri CRL 1098 in exponential growth phase (MRS medium, uncontrolled pH)
was able to produce active LrS (reduction TNF-α production in PBMC) [18] (Fig 1). With this
approach, the ability of bacterial cells at different phases of growth, obtained from controlled
and uncontrolled pH cultures (early exponential, late exponential and stationary phases) to
produce anti-inflammatory LrS in RPMI 1640 medium was evaluated. At uncontrolled pH,
the anti-inflammatory activity of LrS obtained from both growth phase, early and late expo-
nential was similar (Fig 4). On the contrary, different results were observed in controlled pH
cultures, in which the anti-inflammatory capacity of LrS depended on the growth phase of the
microorganism. The anti-inflammatory activity was only observed in LrS obtained from bio-
mass in late exponential phase. Regardless the pH conditions of the cultures, the LrS obtained
from the biomass at the stationary phase showed a high cytotoxicity on RAW 264.7 cells (data
not shown).
When the production of TNF-α was evaluated as a marker of inflammation, it was observed
that the LrS obtained from uncontrolled pH cultures in both early and late exponential phases,
showed a significant decrease (p 0.05) of this marker (50 and 38%, respectively) regarding
the control of cells stimulated with LPS (Fig 5).
The quantification of the two inflammatory markers (NO and TNF-α) allowed us to opti-
mize the first stepof biomass production (Fig 1) establishing the conditions of L. reuteri
CRL1098 culture: PETG medium, uncontrolled pH, agitation (150 rpm), 37˚C and harvest of
the biomass in late exponential growth phase (6h of incubation).
Fig 3. L. reuteri CRL1098 growth in PETG medium under controlled and uncontrolled pH. (black circle) pH-
controlled culture (gray circle) pH-uncontrolled culture; (gray triangle) pH.
https://doi.org/10.1371/journal.pone.0200426.g003
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Second step: Formulation of a low-cost medium for anti-inflammatory LrS
production
In a second step, we aimed to formulate a low cost medium for LrS production. Previously,
LrS was obtained after 4h incubation time of L. reuteri CRL1098 in RPMI 1640 medium(129
Fig 4. Effect of LrS obtained in RPMI medium on NO production by RAW 264.7 macrophages. RAW 264.7 cells
were challenged with LPS and LrS obtained from bacteria grow in PETG medium in early and late exponential phase,
at controlled and uncontrolled pH conditions. Cells with a without LPS challenge were used as control. NO production
was measured in culture supernatants by Griess assay. Data shown are a representative result of three independent
experiments. Values not sharing the same letter were significantly different (p-value<0.05).
https://doi.org/10.1371/journal.pone.0200426.g004
Fig 5. Effect of LrS on TNF-α production by RAW 264.7 cells. LrS production by bacteria grow in PETG medium in
early and late exponential growth phase was evaluated in RPMI 1640 medium, and their anti-inflammatory effect was
checked on LPS challenged RAW cells. TNF-α production was measured in culture supernatants by ELISA. Data
shown are a representative result of three independent experiments. Values not sharing the same letter were
significantly different (p-value<0.05).
https://doi.org/10.1371/journal.pone.0200426.g005
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USD/L) in our laboratory (Fig 1). In these conditions, the microorganism was able live but did
not proliferate.
Considering the results of the previous point, L. reuteri CRL1098 biomass was obtained
from PETG culture medium in optimized conditions. Subsequently, this biomass was sus-
pended in different media and buffers. Bacteria survival assay in different media and buffers
was performed during 4h at 37 ˚C under agitated condition. Results indicated that L. reuteri
CRL1098 only lived, but with a non-proliferating condition in casitone medium (1%) and
sodium citrate buffer with 4 g/L glucose as carbon source (Table 3).
To evaluate anti-inflammatory activity of LrS obtained from casitone medium and
citrate buffer, LPS stimulates RAW 264.7 cells were treated with both LrS. TNF-α produc-
tion was determined in culture supernatant (Fig 6). Both LrS diminished TNF-α: 72% dimi-
nution induced by LrS obtained in casitone medium and 61% by LrS obtained in citrate
buffer.
Table 3. Viability of L. reuteri CRL1098 in different media after 4h at 37 ˚C under agitating condition.
Media Growth (Log CFU/mL)
0 h 2 h 4 h
RPMI 1640 7.60 ± 0.08 7.44 ± 0.07 7.40 ± 0.25
DMEM 7.75 ± 0.03 6.49 ± 0.08 5.48 ± 0.10
Casitone 1% 7.77 ± 0.05 7.72 ± 0.05 7.61 ± 0.12
Casitone 1:10 7.44 ± 0.02 7.19 ± 0.05 6.73 ± 0.01
Casitone 1:20 7.53 ± 0.02 7.23 ± 0.04 6.83 ± 0.06
Casitone + Glucose 4 (g/L) 7.56 ± 0.04 7.83 ± 0.05 8.30 ± 0.13
Tris buffer + Glucose 4 (g/L) 7.64 ± 0.03 7.56 ± 0.01 6.45 ± 0.04
Sodium citrate buffer + Glucose 4 (g/L) 7.62 ± 0.10 7.63 ± 0.04 7.69 ± 0.07
PBS buffer + Glucose 4 (g/L) 7.76 ± 0.13 7.28 ± 0.08 6.52 ± 0.06
https://doi.org/10.1371/journal.pone.0200426.t003
Fig 6. Effect of LrS on TNF-α production by RAW 264.7 macrophages. LrS production by bacteria grow in PETG medium (late
exponential growth phase, pH-uncontrolled culture) was evaluated in casitone medium and sodium citrate buffer, and their anti-
inflammatory effect was checked on LPS challenged RAW cells. TNF-α production was measured in culture supernatants. Data
shown are a representative result of three independent experiments. Values not sharing the same letter were significantly different
(p-value<0.05).
https://doi.org/10.1371/journal.pone.0200426.g006
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Casitone medium (4.39 USD/L) is hydrolyzed casein composed of a large percentage of
peptides that could interfere in the determination of anti-inflammatory activity. For these rea-
sons, citrate buffer was selected as the optimal means for producing the anti-inflammatory
compound. It is a simple and economical buffer (2.37 USD/L) that allows the obtention of an
acceptable level of anti-inflammatory activity.
Discussion
Research reports revealed that certain extracellular peptides produced by probiotic bacteria are
responsible for some of their beneficial effects [21–22]. In these works, culture supernatant
containing the functional peptides is used, not the purified peptides, despite the fact that its
amino acid sequence is available [21–25]. In addition, it has been found that the effect of cul-
ture supernatant or purified peptides is similar. Thus, this point would be of great industrial
importance since aculture supernatant could be used and whose production is of lower cost
than a purified peptide production obtained with the use of heterologous strain to overexpress
this peptide. On the other hand, the chemical synthesis of peptides to a large scale has a high-
cost [26]. We have demonstrated previously that a LrS produced by L.reuteri CRL1098 modu-
lates the inflammatory response in vitro and in a mice model. In this work, we propose an eco-
nomic process of LrS realized through two steps: biomass and LrS production.
Regarding the first step, usually the probiotic LAB production involves batch growth in
large-scale bioreactors. LAB batch culture has been extensively studied before [27–30]. These
studies evaluate the application of economic and more competitive culture media for biomass
production, because the growth medium is the most expensive factorat an industrial level [31].
Statistical models are often used for simplified media formulation, through the exclusion or
reduction of components of the medium [15, 32, 33]. The initial approach involves the use of a
statistical model, employing the conventional laboratory medium MRS. MRS broth remains
the most widely used culture medium for LABgrowth [34]. However, it is too expensive for
industrial applications [15]. In this work, MRS medium is used for biomass production in the
first step of the studied process. The experiments were performed with different combinations
of ten MRS factors to determine their impact on biomass production by using a fractional fac-
torial design. The statistical design allowed us to reduce the number of experimental runs, to
identify the important factors, and to determine the interaction between factors without losing
the information on the main effects and their interactions [35]. Among the ten factors studied,
only meat peptone, meat extract and Tween 80 had significant influence on the growth of L.
reuteri CRL1098. Therefore, these components were required for optimal biomass production.
Several studies have reported the nutrients influence on LAB biomass production, mainly the
positive effect of nitrogen sources, such as, peptone and meat extract. Protein hydrolyzates are
widely used in LAB growth culture and account for 70% of the total cost of medium [31, 36].
However, different authors reported the strong effect of nitrogen sources on the growth of Lac-
tobacillus strains, such as, L. casei KH-1 [37], L. acidophilus FTCC 0291 [35], L. rhamnosus E/N
[33] and L. reuteri [38]. Hebert et al. [39] showed that Tween 80 had different effects on the
growth of several LAB: it has stimulated L. delbrueckii subsp. bulgaricus NCFB 2772 and has
inhibited L. sake NCFB 2714. On the contrary, this compound was essential for L. curvatus
[40] and had a great positive effect on the growth of L. reuteri [39]. Our results showed a posi-
tive curve slope indicating a strong effect of Tween 80 on L. reuteri CRL1098 biomass produc-
tion. According to statistical design (Table 2), many components in MRS medium, such as,
sodium acetate, yeast extract, K2HPO4, ammonium citrate, glucose, MgSO4.7H2O and
MnSO4.H2O, were considered not to have a significant effect on the biomass production in the
assay conditions. Therefore, these components could be removed from the medium without
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influencing bacterium growth. This was reported by Mataragas et al. [41] for Leuconostoc
mesenteroides L124 and L. curvatus L442, having similar results. Our present results showed
the predicted optimal components concentration: 0.5% meat peptone, 0.5% meat extract, 0.1%
Tween 80 and 0.5% glucose. In view of these optimal components a PETG culture medium
was designed, one sustained L. reuteri CRL 1098 growth. In addition, LrS from PETG culture
medium showed the anti-inflammatory effect on LPS stimulated RAW 264.7 cells. The analysis
of costs indicated that the PETG culture medium price is 3.81 USD/L, 2.4 times lower than
MRS medium cost (9.27 USD/L).
In this study, the simultaneous evaluation of the effect of different factors on the growth
and LrS production of a Lactobacilus strain was performed. Biomass production was found to
depend mainly on culture medium, while LrS production with anti-inflammatory activity
depended of culture conditions such as pH, agitation and growth phase. Previous studies
showed that fermentation parameters and culture conditions affect the biomass yield as well as
the functional properties of Lactobacillus [42, 43]. Aguirre-Ezkauriatza et al. [44] reported that
under agitating conditions, higher biomass was acquired as compared to static condition,
because agitation enhances microbial growth by improving the distribution of nutrients
through the fermentation tank. In our study, we found similar L. reuteri CRL1098 growth
under static and agitating conditions. Nevertheless, the best anti-inflammatory response was
observed in cell free supernatant obtained from bacterial culture under agitating condition. L.
reuteri is considered an oxygen-tolerant anaerobe with fermentative metabolism. The growth
condition and the type of metabolism significantly affect the stress responses in LAB. Several
studies have demonstrated that conditions which promote aerobic and respiratory growth
(agitation) induce stress tolerance in Lactobacillus [45]. So, this growth condition could also
have influenced the ability of L. reuteri to produce active LrS (second step, under cell starvation
conditions).
Other important parameter for cultivating LAB is the pH of the fermentation [11]. Numer-
ous studies indicate that the medium pH can influence the microorganisms´ growth, affecting
cellular functions and metabolic processes [46, 47]. Rault et al. [48] showed that the pH influ-
enced the growth behavior of lactobacilli and the final yield obtained, although substantial dif-
ferences can be observed, depending on the strain. The control of fermentation pH has also
been used to improve metabolite production of LAB [41, 49, 50]. The optimum pH range for
the growth of LAB varies from 3.5 to 6.5 [51]. LeBlanc et al. [52]observed a similar bacterial
growth of Lactobacillus strains at different pH conditions of the fermentation medium. How-
ever, our experiment showed a significant viability decrease after 6h of fermentation under
controlled pH; this could be explained by the fast glucose consumption (82% at 6 h).
Probiotic bacteria at an industrial level are commonly harvested during the stationary
growth phase to ensure the highest biomass production [53]. In the present work, the LrS
obtained from L. reuteri CRL1098 harvested at stationary phase in both controlled and uncon-
trolled pH conditions showed a high cytotoxicity on RAW 264.7 cells. This could be due to the
production of some toxic metabolite during this growth phase. Some works reported that the
growth phase during which probiotics are harvested can influence their capability as health-
promoting agents [53]. Deepika et al. [54] reported that cell surface properties of L. rhamnosus
GG change during the transition from the exponential to the stationary growth phase, affecting
the ability of the strain to adhere to epithelial cells. Lactobacillus strains can differentially affect
antigen-specific antibody subclasses IgG1 and IgG2a, dependent on the growth phase. Accord-
ing to Maassen et al. [55], this differential antibody response is due to growth phase-dependent
differences in bacterial cell wall composition. Proteins secreted by probiotic LAB at early sta-
tionary growth phase were reported in other works; however, they are produced in MRS
medium [56, 57].
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At laboratory scale LrSproduction (second step) was produced only under stress conditions
in RPMI 1640 medium, where the bacteria was able to live but did not proliferate [18]. Some
preliminary assays revealed that when the LrS production medium (RPMI medium) was mod-
ified by increasing glucose or by adding some essential components (adenine, alanine, gluta-
mine or Tween 80), L. reuteri CRL 1098 grew but the supernatant lost the anti-inflammatory
effect. These results showed that the compound is not associated with the growth of L. reuteri
(unpublished data). Also, the RPMI 1640 medium used in the second step of LrS production is
very expensive (129 USD/L). Therefore, the design of an economic and more competitive
medium for LrS production represented an important step for its application at an industrial
scale. In order tochange the medium for LrS production for industrial uses, we evaluated the
effect of economic media and buffer solutions. Up to date, we did not find reports about cul-
ture media optimization for LAB peptides production under non-proliferating conditions. In
contrast, several studies reported culture media optimization for bacteriocins production by
LAB, antimicrobial peptides which synthesis is associated with bacteria growth [15, 58–60]. In
this work,sodiumcitrate buffer with glucose (2.37 USD/L) was selected for the anti-inflamma-
tory compound production. Moreover, LrS obtained in sodium citrate buffer had an anti-
inflammatory activity similar from that obtained in RPMI 1640 medium. Farias and Manca de
Nadraet al. [61] reported that Oenococcus oeni showed extracellular proteolytic activity with
exoprotease production when subjected to a total energy and nutrient starvation regime (2 h
of incubation in citrate buffer). The production of metabolites by starved bacterial suggests
that it could be an effective mechanism for survival in the stress conditions encountered dur-
ing starvation.
Conclusions
Based on the studies presented in this work, the two-step production of the anti-inflammatory
compound by L. reuteri CRL1098 was optimized. Our results suggest that the fermentation
procedures are important for the industrial production of probiotics or its active metabolites.
The cost analysis reveals the importance of the obtained results: 6.18 USD/L is the cost of pro-
ducing the LrS with anti-inflammatory activity in the optimized process (PETG culture
medium: 3.81 USD/L, citrate buffer: 2.37 USD/L), compared to 138 USD/L price that responds
to the original laboratory scale process (Fig 1). In this analysis, only the item supplies (culture
media, reagents, drugs) were considered for its impact on the production process, as a starting
point for its optimization. The overall results demonstrated that the strategies applied allowed
a 95% cost reduction from the original laboratory-scale process.
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